In silico and in vitro antimalarial activity evaluation of eugenol’s transformation products against Plasmodium falciparum strain 3D7 using the Trager and Jensen method
Research reveals potential antimalarial effects of eugenol transformation products against Plasmodium falciparum, suggesting new drug development avenues.
Key Points
Compounds derived from eugenol transformation exhibit strong antimalarial activity against Plasmodium falciparum.
Notably, two compounds showed IC50 values of less than 1 µM, categorizing them as highly effective.
Molecular docking and dynamics studies were conducted against plasmepsin II, enhancing the understanding of compound effectiveness.
Further research will focus on cytotoxic assays and optimizing pharmacokinetic properties of the best-performing compounds.